Curcumin inhibits the metastasis of K1 papillary thyroid cancer cells via modulating E-cadherin and matrix metalloproteinase-9 expression

Biotechnology Letters

Volumn 35, Issue 7, 2013, Pages 995-1000

  Zhang, Chi Yu ^a   Zhang, Li ^b   Yu, Hui Xin ^b   Bao, Jian Dong ^b   Lu, Rong Rong ^a  

^a JIANGNAN UNIVERSITY   (China)

^b BEIJING HOSPITAL   (China)

Author keywords

Curcumin; E cadherin; Matrix metalloproteinases; Metastasis; Thyroid cancer

Indexed keywords

CURCUMIN; E-CADHERINS; MATRIX METALLOPROTEINASES; METASTASIS; THYROID CANCERS;

DISEASES; GLYCOPROTEINS; PATHOLOGY;

ENZYME INHIBITION;

ANTINEOPLASTIC AGENT; CADHERIN; CURCUMIN; GELATINASE B;

ARTICLE; CELL MOTION; DRUG EFFECT; HUMAN; METABOLISM; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; CADHERINS; CELL LINE, TUMOR; CELL MOVEMENT; CURCUMIN; HUMANS; MATRIX METALLOPROTEINASE 9;

EID: 84878928131     PISSN: 01415492     EISSN: 15736776     Source Type: Journal    
DOI: 10.1007/s10529-013-1173-y     Document Type: Article

References (13)

1. Chen H-W, Lee J-Y, Huang J-Y, Wang C-C, Chen W-J, Su S-F, Huang C-W, Ho C-C, Chen JJW, Tsai M-F, Yu S-L, Yang P-C (2008) Curcumin inhibits lung cancer cell invasion and metastasis through the tumor suppressor HLJ1. Cancer Res 68: 7428-7438.
2. Forsyth PA, Wong H, Laing TD, Rewcastle NB, Morris DG, Muzik H, Leco KJ, Johnston RN, Brasher PM, Sutherland G, Edwards DR (1999) Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas. Br J Cancer 79: 1828-1835.
3. Kunnumakkara AB, Anand P, Aggarwal BB (2008) Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins. Cancer Lett 269: 199-225.
4. Leow PC, Tian Q, Ong ZY, Yang Z, Ee PL (2010) Antitumor activity of natural compounds, curcumin and PKF118-310, as Wnt/beta-catenin antagonists against human osteosarcoma cells. Invest New Drugs 28: 766-782.
5. Nawrocki-Raby B, Gilles C, Polette M, Martinella-Catusse C, Bonnet N, Puchelle E, Foidart JM, van Roy F, Birembaut P (2003) E-Cadherin mediates MMP down-regulation in highly invasive bronchial tumor cells. Am J Pathol 163: 653-661.
6. Onder TT, Gupta PB, Mani SA, Yang J, Lander ES, Weinberg RA (2008) Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. Cancer Res 68: 3645-3654.
7. Rajoria S, Suriano R, George A, Shanmugam A, Schantz SP, Geliebter J, Tiwari RK (2011) Estrogen induced metastatic modulators MMP-2 and MMP-9 are targets of 3, 3′-diindolylmethane in thyroid cancer. PLoS One 6: e15879.
8. Ray S, Chattopadhyay N, Mitra A, Siddiqi M, Chatterjee A (2003) Curcumin exhibits antimetastatic properties by modulating integrin receptors, collagenase activity, and expression of Nm23 and E-cadherin. J Environ Pathol Tox 22: 49-58.
9. Shankar S, Srivastava RK (2012) Curcumin: structure, biology and clinical applications. In: Shankar S, Srivastava RK (eds) Nutrition, diet and cancer, 1st edn. Springer, Netherlands, pp 413-457.
10. Song F, Zhang L, Yu H-X, Lu R-R, Bao J-D, Tan C, Sun Z (2012) The mechanism underlying proliferation-inhibitory and apoptosis-inducing effects of curcumin on papillary thyroid cancer cells. Food Chem 132: 43-50.
11. Vasko VV, Saji M (2007) Molecular mechanisms involved in differentiated thyroid cancer invasion and metastasis. Curr Opin Oncol 19: 11-17.
12. Weng CJ, Yen GC (2012) Chemopreventive effects of dietary phytochemicals against cancer invasion and metastasis: phenolic acids, monophenol, polyphenol, and their derivatives. Cancer Treat Rev 38: 76-87.
13. Zuo H, Gandhi M, Edreira MM, Hochbaum D, Nimgaonkar VL, Zhang P, DiPaola J, Evdokimova V, Altschuler DL, Nikiforov YE (2010) Downregulation of Rap1GAP through epigenetic silencing and loss of heterozygosity promotes invasion and progression of thyroid tumors. Cancer Res 70: 1389-1397.